Patrick MICHEL,Jérémie LAVAUR,Etienne HIRSCH,Marc LEMAIRE,Jan PYPE
申请号：
US14903809
公开号：
US20160151412A1
申请日:
2014.07.03
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The invention relates to a gaseous medication containing xenon, preferably in an amount of less than 75% by volume, for use by inhalation, in combination with at least one NMDA receptor antagonist in the form of a liquid or solid, in particular memantine, for treating, slowing or preventing neurological deterioration consequent upon a neurodegenerative disease, in particular Alzheimers disease, in a human patient.
